News
CVS Health, one of the nation’s largest pharmacy benefit managers, has declined to cover Gilead’s newly FDA-approved HIV ...
Dealbreaker on MSN3h
Gilead Sciences Gains In Vivo Cell Therapy Capability With $350M Interius Bio Acquisition
Kite, the Santa Monica, California-based cell therapy subsidiary of Gilead, has entered a definitive agreement to pay $350 ...
Fort Worth’s oldest African American Baptist church, which was recently put on a list of Most Endangered Places in the city, ...
On Friday, the U.S. District Court for the District of Maryland paused several parts of a health insurance exchange enrollment and eligibility rule that was set to take effect today. The court agreed ...
Imdelltra is a first-in-class immunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) marketed by A ...
Rough Draft Atlanta on MSN20h
CVS Health withholds coverage for new HIV prevention drug
CVS Health, one of the nation’s largest pharmacy benefit manager companies that play a lead role in deciding which drugs are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback